Effect of bezafibrate on endothelial dysfunction induced by postprandial hypelipidemia

Effect of bezafibrate on endothelial dysfunction induced by postprandial hypelipidemia - Effect of bezafibrate on endothelial dysfunction induced by postprandial hypelipidemia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012557

Enrollment

Registered

2013-12-12

Start date

2013-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with metabolic syndrome

Interventions

orally bezafibrate treatment No treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients wiht metabolic syndrome 2)Subjects who obtained written-informed consent for study participation

Exclusion criteria

Exclusion criteria: Patients treated with hypoglycemic agents and/or lipid-lowering agents Patients having allergy for research reagents

Design outcomes

Primary

Measure	Time frame
Change in FMD during postprandial state at baseline and after bezafibrate treatment	—

Countries

Japan

Contacts

Public ContactToru Miyoshi

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Cardiovascular Medicine

miyoshit@cc.okayama-u.ac.jp086-235-7351

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026